Reported Standalone quarterly numbers for Vivimed Labs are:
Net Sales at Rs 22.58 crore in March 2025 down 37.95% from Rs. 36.38 crore in March 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 4.42 crore in March 2025 down 180.12% from Rs. 5.51 crore in March 2024.
EBITDA stands at Rs. 1.67 crore in March 2025 up 110.69% from Rs. 15.62 crore in March 2024.
Vivimed Labs shares closed at 4.95 on July 31, 2023 (NSE)
Story continues below Advertisement
| Vivimed Labs | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'25 | Dec'24 | Mar'24 | | Net Sales/Income from operations | 22.58 | 34.23 | 36.38 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 22.58 | 34.23 | 36.38 | | EXPENDITURE | | Consumption of Raw Materials | 12.34 | 15.81 | 30.92 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -0.83 | 5.61 | -18.60 | | Power & Fuel | -- | -- | -- | | Employees Cost | 7.07 | 5.93 | 5.69 | | Depreciation | 4.61 | 6.37 | 4.96 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 6.47 | 7.07 | 41.37 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -7.09 | -6.55 | -27.95 | | Other Income | 4.15 | 0.00 | 7.37 | | P/L Before Int., Excpt. Items & Tax | -2.94 | -6.54 | -20.58 | | Interest | 1.48 | 0.43 | -33.69 | | P/L Before Exceptional Items & Tax | -4.42 | -6.97 | 13.11 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -4.42 | -6.97 | 13.11 | | Tax | -- | -- | 1.77 | | P/L After Tax from Ordinary Activities | -4.42 | -6.97 | 11.34 | | Prior Year Adjustments | -- | -- | -5.83 | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -4.42 | -6.97 | 5.51 | | Equity Share Capital | 16.58 | 16.58 | 16.58 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.53 | -0.84 | 0.66 | | Diluted EPS | -0.52 | -0.82 | 0.65 | | EPS After Extra Ordinary | | Basic EPS | -0.53 | -0.84 | 0.66 | | Diluted EPS | -0.52 | -0.82 | 0.65 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
